Keywords: Evotec, DeveloGen, M&A, Germany, Drug discovery, Diabetes, etablic and endocrine diseases

Evotec acquires DeveloGen in a 14 million-euro deal

Article | 19 July 2010

Evotec AG has signed a definitive agreement to acquire fellow Germany-based DeveloGen, a biopharmaceutical company engaged in the discovery of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Evotec

DeveloGen

Go to company listing